Half Year 2020 Imricor Medical Systems Inc Earnings Call Transcript
Thank you for standing by, and welcome to the Imricor Medical Systems HY '20 Results Investor Briefing. (Operator Instructions) I would now like to hand the conference over to Mr. Steve Wedan, Chair and CEO. Please go ahead.
Thank you. Hello, everyone, and thank you for joining us today to discuss the half year results for Imricor. I'm Steve Wedan, Imricor's Chair and CEO, and I'm joined today by our CFO, Lori Milbrandt.
Today, I will take you through Imricor's key achievements during 2020, discuss the impacts of the COVID-19 pandemic and provide you with an update on the business as well as our market and growth opportunities moving forward. Lori will discuss the financial results for the 6 months to 30 June, before I take you through our outlook. We'll then move to a Q&A session.
We started 2020 in an exciting position, achieving a long-awaited CE mark approval, which enabled us to begin to sell our products in the European Union, and we moved swiftly
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |


